“…Many previous works demonstrated that various diameter TiO 2 NT structures can also induce the anti-inflammatory response of hosts (Chamberlain et al [21], Smith et al [189], Neacsu et al [20], Yao et al [190], Bai et al [191]). The surface modification induced by the nanotube structures combined with annealing can change the hemocompatibility of TiO 2 NTs, by alleviating platelet activation (Mazare et al [111,150], Junkar et al [15], Huang et al [192], Gong et al [193], Bai et al [191,194]). Several in vivo studies have shown that TiO 2 nanotubular layers could induce successful peri-implant bone formation/osseointegration in various animal models using different diameter NTs: von Wilmowsky et al (30 nm diameter nanotubes) [195], Wang et al (30,70, and 100 nm diameter NTs) in minipigs [174], Alves-Rezende et al (≈ 74 nm diameter NTs) [196], Baker et al (TiO 2 NTs-in vitro and in vivo intramedullary fixation) in rats [197], or the review of Wang et al [198] for the effect of TiO 2 NTs grown on the implants' surface on osseointegration in animal models.…”